Vifor Pharma and Chemocentryx Announce Expansion of Kidney Health Alliance to Include CCX140 Pharmaceutical Investing
RespireRx Pharmaceuticals Inc. Announces Positive Results from Phase 2B PACE Study Conducted by the University of Illinois Dronabinol Reduces Symptoms of Obstructive Sleep Apnea Company News
Great Basin Scientific Shareholders Approve Reverse Stock Split and Authorized Share Increase During Special Meeting Medical Device Investing
Helix BioPharma Announces the Signing of a Non-Binding Letter of Intent With ProMab Biotechnologies to Develop Cell Based Therapies Life Science Investing
Immunomedics Awarded Additional Intellectual Property Protection for IMMU-140, an Antibody-Drug Conjugate With Dual-Therapeutic Potential Pharmaceutical Investing
Protalix BioTherapeutics Announces Last Patient Enrolled in the AIR DNase™ Phase II Clinical Trial for Cystic Fibrosis Pharmaceutical Investing
Cannabis Science Orders Multiple Greenhouse Structures for its 2nd Pilot 33,000 Sq. Ft. Drug Development Facility Buildout Life Science Investing
Pluristem and Sosei CVC to Establish New Corporation for the Commercialization of PLX-PAD in Japan Genetics Investing
Bristol-Myers Squibb and Calithera Biosciences Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with CB-839 in Clear Cell Renal Cell Carcinoma Biotech Investing
